Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

First-line therapy in head and neck cancer with docetaxel/cisplatin

Baur M, Kienzer H, Schweiger J, DeSantis M, Poehnl R, Schernhammer E, Postner G, Kraus R, Pont J, Schratter-Sehn A, Wicke W, Dittrich CH. First-line therapy in head and neck cancer with docetaxel/cisplatin. Ann Oncol (Pro ESMO, Athens, Greece). 1998; 9(Suppl 4):362.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.